Calvin Law

578 citations
8 papers · 232 indexed · 1 hit paper · h-index 7
Topics
interferon and immune responses (2 papers)CRISPR and Genetic Engineering (2 papers)CAR-T cell therapy research (2 papers)
Partner nations
United StatesFrance

In The Last Decade

Calvin Law

7 papers receiving 228 citations

Hit Papers

Naturally occurring T cell mutations enhance engineered T...202420262025202410203040

Peers

Calvin Law
Comparison fields: 5 of 55
  • Molecular Biology 127
  • Oncology 85
  • Immunology 82
  • Cancer Research 39
  • Cellular and Molecular Neuroscience 19
Replace Hae-Kyung Lee with:
Hae-Kyung Lee South Korea
Hikaru Hanyu Japan
Jiwon Huh South Korea
Zhenzhan Kuang China
George F. Harris United States
Quintin Lee Australia
Willine J. van de Wetering Netherlands
Carina A. Bäuerlein Germany
Jason J. Hu United States
Jana Koth United Kingdom
Calvin Law relative to Hae-Kyung Lee South Korea Hae-Kyung Lee's profile →
Citations per field
00.5×1.5×2.5×
Hae-Kyung Lee · 1×
Citations per year

Countries citing papers authored by Calvin Law

Since Specialization
Citations

This map shows the geographic impact of Calvin Law's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calvin Law with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calvin Law more than expected).

Fields of papers citing papers by Calvin Law

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Calvin Law. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calvin Law. The network helps show where Calvin Law may publish in the future.

Co-authorship network of co-authors of Calvin Law

This figure shows the co-authorship network connecting the top 25 collaborators of Calvin Law. A scholar is included among the top collaborators of Calvin Law based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Calvin Law. Calvin Law is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1
Naturally occurring T cell mutations enhance engineered T cell therapiesbreakdown →
46
2 0
3 13
4 28
5 30
6 22
7 81
8 12

About Calvin Law

Calvin Law is a scholar working on Endocrinology, Oncology and Immunology, having authored 8 papers that have together received 232 indexed citations. Recurring topics across this work include interferon and immune responses (2 papers), CRISPR and Genetic Engineering (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Immunology (82 citations), Oncology (85 citations) and Cancer Research (39 citations). Calvin Law has collaborated with scholars based in United States and France. Frequent co-authors include Andrea E. Murmann, Marcus E. Peter, William Putzbach, Sonia Brockway, Abdul S. Qadir, Jindan Yu, Jonathan C. Zhao, Huiping Liu, Arthur R. Salomon and Jaehyuk Choi. Their work appears in journals such as Nature, Blood and Cell Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026